LEMAITRE VASCULAR INC
About LEMAITRE VASCULAR INC
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $249.6M
- Net income
- $57.7M
- Total assets
- $615.7M
- Market cap
- $2.2B
- Gross margin
- 71.5%
- Operating margin
- 27.2%
- Net margin
- 23.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $249.6M
- Cost of revenue
- $71.1M
- Gross profit
- $178.5M
- Operating expenses
- $110.6M
- Operating income
- $67.9M
- Income tax
- $17.4M
- Net income
- $57.7M
- EPS (basic)
- $2.55
- EPS (diluted)
- $2.52
Balance sheet
- Total assets
- $615.7M
- Current assets
- $468.2M
- Total liabilities
- $222.2M
- Current liabilities
- $36.3M
- Shareholders’ equity
- $393.5M
Cash flow
- Operating cash flow
- $81.3M
- Investing cash flow
- -$64.9M
- Financing cash flow
- -$14.5M
- Net cash flow
- $1.8M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $2.2B
- P/E ratio
- 36.6
- EPS (diluted)
- $2.52
- Dividend yield
- 1.08%
- Shares outstanding
- 23.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 19, 2006
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $57.7M in FY2025.
- Revenue grew 93% from FY2020 to FY2025.
- Gross margin of 71.5%, net margin 23.1%.
- Trading 21% below its 52-week high.
- Pays a dividend yielding about 1.08% annually.
- Valued at a price-to-earnings (P/E) ratio of 36.6.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review LEMAITRE VASCULAR INC.
Write a review
News about LEMAITRE VASCULAR INC
News & sentiment via Polygon.io
